Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Ann Fr Anesth Reanim ; 32(9): e97-e101, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23953836

ABSTRACT

PURPOSE: To estimate the agreement between radial or femoral, and ascending aortic invasive blood pressure values. PATIENTS AND METHODS: Prospective study on 32 patients who underwent an aortic endografting under general anesthesia. After deploying the prosthesis under controlled hypotension, a catheter was introduced in the aorta to measure the staged systolic (SAP), diastolic (DAP) and mean (MAP) arterial pressures, in particular at the level of ascending aorta and femoral artery. RESULTS: No differences were observed between SAP, DAP or MAP measured in the aorta versus femoral or radial arteries. A better agreement was observed between the aortic and femoral MAP (bias of 1mmHg, limits of agreement between: -8.8mmHg and +10.8mmHg) than between the aortic and the radial MAP (bias of 1.7mmHg, limits of agreement between: -14.1mmHg and +17.5mmHg). The comparison between radial and femoral MAP was not satisfying (bias of -4.7mmHg and limits of agreement between -19.1mmHg and +9.7mmHg). CONCLUSION: The femoral MAP is more accurate to predict value of the aortic MAP than the radial MAP in a hypotensive setting. The clinician should be aware of these discrepancies in conditions of hemodynamic impairment to optimize the treatment.


Subject(s)
Aorta/physiology , Blood Pressure/physiology , Femoral Artery/physiology , Heart Valve Prosthesis Implantation , Radial Artery/physiology , Aged , Anesthesia, General , Arterial Pressure/physiology , Cardiac Catheterization , Echocardiography, Transesophageal , Female , Humans , Hypotension, Controlled , Male , Middle Aged , Monitoring, Intraoperative , Prospective Studies , Regional Blood Flow/physiology
2.
Semin Intervent Radiol ; 24(2): 167-79, 2007 Jun.
Article in English | MEDLINE | ID: mdl-21326794

ABSTRACT

Type A aortic dissection remains fatal if untreated. Although classical medical therapy for type B dissection is considered the therapy of choice in uncomplicated cases, the paradigm is changing as greater experience is accrued with endovascular treatments and technical advances improve the long-term outlook. Diagnosis is also becoming more sophisticated, allowing greater appreciation of the anatomy of dissections and improving the knowledge base as their natural history is assessed.

3.
Arch Mal Coeur Vaiss ; 99(12): 1215-24, 2006 Dec.
Article in French | MEDLINE | ID: mdl-18942524

ABSTRACT

The endovascular treatment of aorta diseases with S-Graft is considered as an alternative to surgery, especially interesting in patients with severe comorbidities. Indeed, the mid-term morbidity and mortality are comparable to surgery in relatively large series, and S-Graft implantation appeared as a safe, less invasive and efficient treatment for different affections of the thoracic aorta. This article reviews technical aspects, indications and results of endovascular repairs of thoracic aorta lesions. We will also assess the advantages and limitations of S-Graft therapy.


Subject(s)
Aorta, Thoracic/surgery , Aortic Diseases/surgery , Stents , Anastomosis, Surgical , Aortic Diseases/mortality , Arterial Occlusive Diseases/surgery , Carotid Arteries/surgery , Humans , Subclavian Artery/pathology , Survival Analysis , Treatment Outcome
4.
Ann Fr Anesth Reanim ; 23(7): 700-3, 2004 Jul.
Article in French | MEDLINE | ID: mdl-15324958

ABSTRACT

OBJECTIVE: The usual treatment of traumatic aortic rupture (TAR) is surgical. This invasive technique necessitating thoracotomy and ECC is associated with a mortality rate of more than 20% and a paraplegia risk of about 10%. New minimally-invasive techniques (aortic stent-grafting) are emerging as less risky alternatives to surgery. We report our experience in the percutaneous treatment of TAR with stent-graft via a surgical femoral cut-down. PATIENTS AND METHODS: Between 1996 and 2002, 23 patients (16-65-year-old, mean 36 years) were treated by thoracic stent-grafting. An informed consent was obtained for every patients. Thirteen patients had an acute or sub-acute TAR (1-8 months, mean 5 months) and five patients had chronic TAR (13-24 years, mean 17 years). The technique was done under general anaesthesia and each patient received a preoperative blood-pressure reduction treatment. During the procedure, anticoagulation (heparin) was given and hypotension was induced when the stent-graft was deployed. Direct positioning control was obtained by means of TEE. RESULTS: Eighty percent of patients were extubed immediately after the procedure. Bleeding was <150 ml. The primary success rate was 100% with one minor type 2 endoleak that was spontaneously resolved after 2 months. There was no case of mortality or paraplegia. There were three minor complications (17%), two haematomas at the arteriotomy site and one inflammatory syndrome characterised by slight fever, raised biological markers but with negative blood culture. CONCLUSION: Percutaneous aortic stent-grafting for TAR is a minimally-invasive technique, which constitute an interesting alternative to surgery. It only necessitates a femoral surgical cut-down compared to the thoracotomy and ECC associated with surgery. The complication rate is low and no mortality or major complication was encountered in our patients. Eventually, the long-term follow-up will allow a widening of indications.


Subject(s)
Aorta, Thoracic/injuries , Aorta, Thoracic/surgery , Minimally Invasive Surgical Procedures , Stents , Vascular Surgical Procedures , Adolescent , Adult , Aged , Anesthesia, General , Anticoagulants/therapeutic use , Echocardiography, Transesophageal , Female , Heparin/therapeutic use , Humans , Male , Middle Aged , Rupture/mortality , Rupture/surgery , Vascular Surgical Procedures/adverse effects
9.
Ann Fr Anesth Reanim ; 4(2): 241-3, 1985.
Article in French | MEDLINE | ID: mdl-2860830

ABSTRACT

A case is reported of anaphylactic shock due to vecuronium occurring in a patient who had already had such a shock, due then to pancuronium, during a previous general anaesthesia. The need for a full immuno-allergological investigation, the occasional efficiency of the anti-histamine premedication, and crossed allergies between muscle relaxants are stressed. It is noted that an anaphylactic shock can be seen on first using a new molecule, as the patient can have been sensitized to it by other muscle relaxants. This case was the first to be described of an anaphylactic shock due to vecuronium bromide.


Subject(s)
Anaphylaxis/chemically induced , Neuromuscular Nondepolarizing Agents/adverse effects , Pancuronium/analogs & derivatives , Pancuronium/adverse effects , Adult , Female , Histamine Antagonists/administration & dosage , Humans , Preanesthetic Medication , Recurrence , Skin Tests , Vecuronium Bromide
SELECTION OF CITATIONS
SEARCH DETAIL
...